The IPO is a binary event for Dror's survival — without it, the company faces imminent liquidity failure. Watch for Nasdaq listing approval and the reverse stock split execution. Post-IPO, monitor commercialization progress of ZSmile and cash burn rate; the company plans to spend ~$1M on R&D over the next 12 months.
Executive Summary
Dror Ortho-Design, a pre-revenue development-stage orthodontic medical device company, filed Amendment No. 4 to its S-1 registration statement for an IPO of up to 3,636,364 shares of common stock (and prefunded warrants) at an assumed price of $4.13 per share, targeting approximately $13.0 million in net proceeds. The company has not generated any revenue, has an accumulated deficit of $23.3 million, and its auditor has expressed substantial doubt about its ability to continue as a going concern. The IPO is critical to fund operations and commercialize its recently FDA-cleared ZSmile platform, but the company faces significant risks including development-stage status, no operating history, and ongoing geopolitical instability in Israel.
Key Facts
- Pre-revenue development-stage company with no operating history in manufacturing or distribution of orthodontic devices.
- Net losses of $2.5 million in 2025 and $5.8 million in 2024; accumulated deficit of $23.3 million as of June 30, 2026.
- Auditor Barzily & Co. expressed substantial doubt about going concern in its February 27, 2026 report.
- Cash of only $93,563 as of June 30, 2026, with negative working capital of $3.75 million.
- IPO seeks to raise ~$13.0M net proceeds (at assumed $4.13/sh) for working capital and general corporate purposes.
- Company expects a 1-for-550 reverse stock split prior to or upon effectiveness of the registration statement.
- Common stock currently trades on OTC Pink at $0.0074/sh (Sept 15, 2026); application pending for Nasdaq Capital Market listing.
- Received FDA 510(k) clearance for ZSmile platform in February 2026 but has not yet commercialized any products.
- Outstanding convertible debentures of $2.325M principal (net $1.87M) will automatically convert into common stock at the IPO price.
- Significant overhang: 1.74 billion shares issuable upon exercise of warrants, preferred stock conversion, and options (pre-split).
Financial Impact
IPO of ~$13.0M net proceeds is critical to avoid near-term liquidity crisis; company had only $93,563 cash as of June 30, 2026.
Risk Factors
- Going concern risk: only $93,563 cash on hand as of June 30, 2026; IPO is essential to fund operations.
- Pre-revenue with no operating history; may never achieve profitability or commercial success.
- Massive dilution: 1.74 billion pre-split shares issuable upon conversion/exercise of existing securities; IPO adds 3.6M post-split shares.
- Nasdaq listing not guaranteed; if denied, offering will not proceed and stock remains on OTC Pink with limited liquidity.
- Operations concentrated in Israel amid ongoing regional conflict, which could disrupt business and supply chain.
- Competition from well-capitalized incumbents like Align Technology, Dentsply Sirona, and Straumann.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001213900-26-100567 |
| Document: ea030549201ex5-1.htm | 0001213900-26-100567 |
| Document: ea030549201ex23-1.htm | 0001213900-26-100567 |
| Document: 0001213900-26-100567-index-headers.html | 0001213900-26-100567 |
| Document: 0001213900-26-100567-index.html | 0001213900-26-100567 |
| Document: 0001213900-26-100567.txt | 0001213900-26-100567 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 5w ago | S-1/A | $0.007400 $0.009000 | ▼ −21.62% | ▼ −20.17% | $0.008500 (−14.86%) |
Aug 19, 2026 9w ago | 8-K | $0.009700 $0.007400 | ▲ +23.71% | ▲ +23.71% | $0.008500 (+12.37%) |
May 1, 2026 25w ago | 8-K | $0.005000 $0.007200 | ▼ −44.00% | ▼ −38.35% | $0.008500 (−70.00%) |
Apr 1, 2026 29w ago | S-1/A | $0.006000 $0.006500 | ▼ −8.33% | ▲ +1.39% | $0.008500 (−41.67%) |
Mar 4, 2026 33w ago | 8-K | $0.007500 $0.006000 | ▼ −20.00% | ▼ −16.21% | $0.008500 (+13.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers